Pharma Equity Group Balance Sheet Health
Financial Health criteria checks 2/6
Pharma Equity Group has a total shareholder equity of DKK25.9M and total debt of DKK43.5M, which brings its debt-to-equity ratio to 168.1%. Its total assets and total liabilities are DKK76.6M and DKK50.7M respectively.
Key information
168.1%
Debt to equity ratio
DKK 43.54m
Debt
| Interest coverage ratio | n/a |
| Cash | DKK 863.00k |
| Equity | DKK 25.90m |
| Total liabilities | DKK 50.74m |
| Total assets | DKK 76.64m |
Financial Position Analysis
Short Term Liabilities: PEG's short term assets (DKK61.8M) exceed its short term liabilities (DKK32.1M).
Long Term Liabilities: PEG's short term assets (DKK61.8M) exceed its long term liabilities (DKK18.6M).
Debt to Equity History and Analysis
Debt Level: PEG's net debt to equity ratio (164.8%) is considered high.
Reducing Debt: Insufficient data to determine if PEG's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: PEG has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: PEG has less than a year of cash runway if free cash flow continues to reduce at historical rates of 54.7% each year